Jane Hsiao

1.4k total citations
20 papers, 1.1k citations indexed

About

Jane Hsiao is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cancer Research. According to data from OpenAlex, Jane Hsiao has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 5 papers in Cancer Research. Recurrent topics in Jane Hsiao's work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers) and RNA Interference and Gene Delivery (4 papers). Jane Hsiao is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers) and RNA Interference and Gene Delivery (4 papers). Jane Hsiao collaborates with scholars based in United States, Taiwan and Japan. Jane Hsiao's co-authors include Olga Khorkova, Claes Wahlestedt, Ross Dixon, Carlos Coito, Matthew S. Lawrence, Marco Magistri, Mohammad Ali Faghihi, Paul Halley, Beena M. Kadakkuzha and Donald J. Weidler and has published in prestigious journals such as Biomaterials, Advanced Drug Delivery Reviews and Journal of Controlled Release.

In The Last Decade

Jane Hsiao

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Hsiao United States 13 694 555 139 82 71 20 1.1k
Ken Iseki Japan 18 536 0.8× 51 0.1× 203 1.5× 128 1.6× 35 0.5× 82 1.2k
Denise Zwanziger Germany 20 385 0.6× 59 0.1× 118 0.8× 74 0.9× 16 0.2× 62 1.1k
Katarzyna Nazimek Poland 20 565 0.8× 225 0.4× 74 0.5× 18 0.2× 5 0.1× 52 992
Anna Caretti Italy 23 741 1.1× 130 0.2× 48 0.3× 75 0.9× 5 0.1× 59 1.2k
Hesheng Luo China 18 325 0.5× 129 0.2× 62 0.4× 41 0.5× 8 0.1× 72 944
Kyriaki Bakirtzi United States 20 481 0.7× 233 0.4× 133 1.0× 179 2.2× 3 0.0× 31 1.1k
Margaret Blount United Kingdom 13 479 0.7× 111 0.2× 24 0.2× 153 1.9× 15 0.2× 18 1.3k
Jerome A. Moore United States 18 267 0.4× 45 0.1× 83 0.6× 117 1.4× 47 0.7× 25 963
Zhiwen Zhang China 20 411 0.6× 137 0.2× 55 0.4× 50 0.6× 4 0.1× 77 983
Zhengtong Pei United States 17 643 0.9× 136 0.2× 50 0.4× 40 0.5× 8 0.1× 24 944

Countries citing papers authored by Jane Hsiao

Since Specialization
Citations

This map shows the geographic impact of Jane Hsiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Hsiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Hsiao more than expected).

Fields of papers citing papers by Jane Hsiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Hsiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Hsiao. The network helps show where Jane Hsiao may publish in the future.

Co-authorship network of co-authors of Jane Hsiao

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Hsiao. A scholar is included among the top collaborators of Jane Hsiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Hsiao. Jane Hsiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tseng, Yung-Chieh, et al.. (2023). Pilot-scale production of inactivated monoglycosylated split H1N1 influenza virus vaccine provides cross-strain protection against influenza viruses. Antiviral Research. 216. 105640–105640. 4 indexed citations
2.
Padmakumar, Smrithi, Gregory Jones, Olga Khorkova, et al.. (2021). Osmotic core-shell polymeric implant for sustained BDNF AntagoNAT delivery in CNS using minimally invasive nasal depot (MIND) approach. Biomaterials. 276. 120989–120989. 19 indexed citations
3.
Padmakumar, Smrithi, Gregory Jones, Olga Khorkova, et al.. (2021). Minimally Invasive Nasal Depot (MIND) technique for direct BDNF AntagoNAT delivery to the brain. Journal of Controlled Release. 331. 176–186. 46 indexed citations
4.
Parayath, Neha N., Carlos Coito, Olga Khorkova, et al.. (2021). Endonasal CNS Delivery System for Blood-Brain Barrier Impermeant Therapeutic Oligonucleotides Using Heterotopic Mucosal Engrafting. Frontiers in Pharmacology. 12. 660841–660841. 8 indexed citations
5.
Khorkova, Olga, Jane Hsiao, & Claes Wahlestedt. (2021). Nucleic Acid–Based Therapeutics in Orphan Neurological Disorders: Recent Developments. Frontiers in Molecular Biosciences. 8. 643681–643681. 16 indexed citations
6.
Navarro‐Partida, José, et al.. (2018). Characterization and Pharmacokinetics of Triamcinolone Acetonide-Loaded Liposomes Topical Formulations for Vitreoretinal Drug Delivery. Journal of Ocular Pharmacology and Therapeutics. 34(5). 416–425. 47 indexed citations
7.
Blokhin, Ilya O., Olga Khorkova, Jane Hsiao, & Claes Wahlestedt. (2018). Developments in lncRNA drug discovery: where are we heading?. Expert Opinion on Drug Discovery. 13(9). 837–849. 44 indexed citations
8.
Hsiao, Jane, Tianyou Yuan, Ming‐Shian Tsai, et al.. (2016). Upregulation of Haploinsufficient Gene Expression in the Brain by Targeting a Long Non-coding RNA Improves Seizure Phenotype in a Model of Dravet Syndrome. EBioMedicine. 9. 257–277. 114 indexed citations
9.
Khorkova, Olga, Jane Hsiao, & Claes Wahlestedt. (2015). Basic biology and therapeutic implications of lncRNA. Advanced Drug Delivery Reviews. 87. 15–24. 268 indexed citations
10.
Tsai, Ming‐Shian, I‐Shing Yu, You‐Tzung Chen, et al.. (2015). Functional and structural deficits of the dentate gyrus network coincide with emerging spontaneous seizures in an Scn1a mutant Dravet Syndrome model during development. Neurobiology of Disease. 77. 35–48. 39 indexed citations
11.
Halley, Paul, Beena M. Kadakkuzha, Mohammad Ali Faghihi, et al.. (2014). Regulation of the Apolipoprotein Gene Cluster by a Long Noncoding RNA. Cell Reports. 6(1). 222–230. 177 indexed citations
12.
Khorkova, Olga, et al.. (2014). Natural antisense transcripts. Human Molecular Genetics. 23(R1). R54–R63. 101 indexed citations
13.
Khorkova, Olga, Jane Hsiao, & Claes Wahlestedt. (2013). Oligonucleotides for Upregulating Gene Expression. Pharmaceutical Patent Analyst. 2(2). 215–229. 7 indexed citations
14.
Dixon, Ross, et al.. (1989). Isolation of a Novel Morphinan 3-O-Diglucuronide Metabolite from Dog Urine. Pharmaceutical Research. 6(1). 28–32. 11 indexed citations
15.
Dixon, Ross, et al.. (1987). Nalmefene: Safety and Kinetics After Single and Multiple Oral Doses of a New Opioid Antagonist. The Journal of Clinical Pharmacology. 27(3). 233–239. 64 indexed citations
16.
Sanderson, John E., Robert W. Caldwell, Jane Hsiao, Ross Dixon, & Ronald R. Tuttle. (1987). Noninvasive Delivery of a Novel Inotropic Catecholamine: Iontophoretic versus Intravenous Infusion in Dogs. Journal of Pharmaceutical Sciences. 76(3). 215–218. 26 indexed citations
17.
Dixon, Ross, John F. Howes, Jane Hsiao, et al.. (1986). Nalmefene: Intravenous safety and kinetics of a new opioid antagonist. Clinical Pharmacology & Therapeutics. 39(1). 49–53. 77 indexed citations
18.
Dixon, Robert K., et al.. (1985). Cardiotonic agents: a simple HPLC procedure for the quantitation of dobutamine and a new congener in plasma.. PubMed. 48(2). 313–6. 1 indexed citations
19.
Dixon, Ross, et al.. (1984). Nalmefene: Radioimmunoassay for a New Opioid Antagonist. Journal of Pharmaceutical Sciences. 73(11). 1645–1646. 12 indexed citations
20.
Hsiao, Jane, et al.. (1983). Nalmefene: quantitation of a new narcotic antagonist in human plasma using high performance-liquid chromatography with electrochemical detection.. PubMed. 42(3). 449–54. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ken Iseki Breakdown of academic impact, for papers by Denise Zwanziger Breakdown of academic impact, for papers by Katarzyna Nazimek Breakdown of academic impact, for papers by Anna Caretti Breakdown of academic impact, for papers by Hesheng Luo Breakdown of academic impact, for papers by Kyriaki Bakirtzi Breakdown of academic impact, for papers by Margaret Blount Breakdown of academic impact, for papers by Jerome A. Moore Breakdown of academic impact, for papers by Zhiwen Zhang Breakdown of academic impact, for papers by Zhengtong Pei
Rankless by CCL
2026